论文信息 - Abstract P1-17-12: Preliminary data from a phase I/II, multicenter, dose escalation study of OP-1250, an oral CERAN/SERD, in subjects with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer - 字舞流文

Abstract P1-17-12: Preliminary data from a phase I/II, multicenter, dose escalation study of OP-1250, an oral CERAN/SERD, in subjects with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer

C. Harmon | P. Klein | P. Kushner | V. Borges | J. Zujewski | D. Makower | E. Hamilton | C. Alemany | Z. Mitri | J. Sparano | M. Patel | David Myles | D. Faltaos | Trinh L. Le | J. Lawrence